Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$104,775,016
+$24,219,720 QoQ
Shares Held
87,354
-0.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#377
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Capital, LLC holds $139,654,335 across 9 Drug Manufacturers - General names. LLY ranks #1 (75.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
87,354 | $104,775,016 | |
| 2 | JNJ |
Johnson & Johnson
|
56,172 | $14,266,002 | |
| 3 | ABBV |
AbbVie Inc.
|
40,087 | $10,087,492 | |
| 4 | AMGN |
Amgen Inc
|
11,787 | $4,268,308 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,111 | $3,483,763 | |
| 6 | PFE |
Pfizer Inc
|
48,093 | $1,158,079 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,250 | $648,225 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,332 | $547,304 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,775,016 | 87,354 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $80,555,296 | 87,582 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $84,590,220 | 78,712 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $59,480,428 | 77,956 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $71,278,664 | 91,438 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $70,723,499 | 85,631 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $29,738,984 | 38,522 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $23,754,709 | 26,813 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $24,377,356 | 26,925 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $20,896,783 | 26,861 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $15,269,589 | 26,195 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $10,825,855 | 20,155 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $9,995,839 | 21,314 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $7,529,140 | 21,924 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $7,974,580 | 21,798 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $7,058,083 | 21,828 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $7,077,292 | 21,828 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $6,236,565 | 21,778 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $6,015,519 | 21,778 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $5,044,283 | 21,832 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,010,880 | 21,832 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,985,617 | 21,334 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $3,587,343 | 21,247 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,146,461 | 21,257 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,489,974 | 21,257 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,948,771 | 21,257 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||